| Status | Acronym | ISRCTN | EudraCT | NCT (clinicaltrials.gov) | DRKS |
|---|---|---|---|---|---|
| Active | P2003GF | 2020-003779-17 | DRKS00024585 |
A clinical trial to assess the efficacy and safety of PB432 in COVID-19 positive inpatients with acute respiratory insufficiency (ARI)
Purpose / Objectives
Primary Outcome
Diagnosis
- COVID-19 infection
Study design
- Phase II
- Phase III
- Multicenter
- Prospective
- Double-blind
- Randomized
- Parallel
- Placebo-controlled
Documents (password protected)
Go to download area (no documents yet)
Responsibilities in overall study
Sponsor
G. Pohl-Boskamp GmbH & Co. KG
(National) Coordinating Investigator
Univ.-Prof. Dr. med. Michael Dreher